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Abstract
Background: Antibiotic treatment for pneumonia as measured by Demographic and Health Surveys (DHS) and Multiple
Indicator Cluster Surveys (MICS) is a key indicator for tracking progress in achieving Millennium Development Goal 4.
Concerns about the validity of this indicator led us to perform an evaluation in urban and rural settings in Pakistan and
Bangladesh.
Methods and Findings: Caregivers of 950 children under 5 y with pneumonia and 980 with ‘‘no pneumonia’’ were
identified in urban and rural settings and allocated for DHS/MICS questions 2 or 4 wk later. Study physicians assigned a
diagnosis of pneumonia as reference standard; the predictive ability of DHS/MICS questions and additional measurement
tools to identify pneumonia versus non-pneumonia cases was evaluated. Results at both sites showed suboptimal
discriminative power, with no difference between 2- or 4-wk recall. Individual patterns of sensitivity and specificity varied
substantially across study sites (sensitivity 66.9% and 45.5%, and specificity 68.8% and 69.5%, for DHS in Pakistan and
Bangladesh, respectively). Prescribed antibiotics for pneumonia were correctly recalled by about two-thirds of caregivers
using DHS questions, increasing to 72% and 82% in Pakistan and Bangladesh, respectively, using a drug chart and detailed
enquiry.
Conclusions: Monitoring antibiotic treatment of pneumonia is essential for national and global programs. Current (DHS/
MICS questions) and proposed new (video and pneumonia score) methods of identifying pneumonia based on maternal
recall discriminate poorly between pneumonia and children with cough. Furthermore, these methods have a low yield to
identify children who have true pneumonia. Reported antibiotic treatment rates among these children are therefore not a
valid proxy indicator of pneumonia treatment rates. These results have important implications for program monitoring and
suggest that data in its current format from DHS/MICS surveys should not be used for the purpose of monitoring antibiotic
treatment rates in children with pneumonia at the present time.
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Introduction
Globally, of the estimated 6.9 million annual deaths in children
younger than 5 y, 1.2 million (18%) die from pneumonia [1].
Prompt treatment with appropriate antibiotics in children with
pneumonia is an effective intervention for reducing mortality
[2,3]. The proportion of children with pneumonia in a population
who receive antibiotic treatment (antibiotic treatment rate) is a key
indicator for tracking progress in achieving Millennium Develop-
ment Goal 4 targets [4]. The validity of this indicator depends on
both the correct identification of pneumonia and the use of an
antibiotic to treat the condition. Current measures of antibiotic use
in pneumonia rely on household-based surveys such as the
Demographic and Health Surveys (DHS) and the Multiple
Indicator Cluster Surveys (MICS). It is, therefore, crucial that
the DHS and MICS measures are reliable and accurate.
Pneumonia indicators in current surveys are based on interviews
with mothers (DHS) or primary caregivers (MICS) using
structured questions on cough and short, rapid breathing or
difficulty in breathing in the previous 2 wk and whether these were
chest-related. The intent is to identify the best possible proxy for
pneumonia in order to assess treatment coverage based on
mother/caregiver recall. Although the DHS survey labels this
condition as ‘‘symptoms of acute respiratory infection,’’ the MICS
survey uses the term ‘‘suspected pneumonia.’’ Irrespective of the
terminology used, for program purposes these cases are classified
as pneumonia. Therefore, the accuracy and reliability of these
questions and the algorithm as a valid proxy of pneumonia in
children has been questioned [5,6], and there is a need to assess
the validity of this approach.
Our primary study objective was to assess the validity of the
caregiver’s responses to the standard DHS/MICS questions about
whether the child had pneumonia in the recent past, and if so, how
it was treated. The reference standard was physician-diagnosed
pneumonia (as per World Health Organization [WHO] defini-
tions) [7]. A further objective was to determine if these measures
can be improved by adding additional questions to the DHS/
MICS surveys or using alternative measurement tools. We also
aimed to assess if there was any difference in a caregiver’s recall at
2 wk (recall period in current DHS/MICS surveys) and 4 wk.
Methods
Ethics Statement
Ethical approval was obtained from the Hospital Ethics
Committee (Pakistan Institute of Medical Sciences), the Ethical
Review Committee of the International Centre for Diarrhoeal
Disease Research, Bangladesh, and the WHO Ethics Review
Committee.
We employed a two-stage written consent procedure: caregivers
were informed about the study and permission was obtained first
at the time of diagnosis and enrollment, and then again at the start
of the follow-up home interviews.
Setting
DHS and MICS surveys are conducted very widely throughout
low- and middle-income countries and in very diverse settings,
which range from rural settings served by community services to
urban and peri-urban settings, where the first level health services
are provided by local hospital outpatient departments. We thus
conducted the study in three diverse urban and rural settings.
The study was conducted in two countries: Pakistan and
Bangladesh. In Pakistan, study participants were recruited in an
urban setting, from the outpatient department of Children’s
Hospital, Pakistan Institute of Medical Sciences, Islamabad,
Pakistan. In Bangladesh, the participants were recruited from
both urban (Dhaka Shishu Hospital, a tertiary pediatric hospital)
and rural (community-based recruitment in four unions [Mirza-
pur, Gorai, Bhatgram, and Jamurki] of Mirzapur, 63 km north of
Dhaka) settings. The latter setting involved initial identification of
pneumonia and ‘‘no pneumonia’’ cases during weekly home visits
by Village Health Workers, later reassessed by study physicians
according to WHO guidelines and enrolled.
Study Design
The study identified and recruited two groups of children with
acute respiratory infections: those who were confirmed to have
pneumonia and those who did not have pneumonia. Two to four
weeks after recruitment caregivers were surveyed to assess the
accuracy of their recall of the diagnosis and treatment given. This
enabled an assessment to be made of the degree to which DHS
and MICS measures of antibiotic treatment in those with reported
symptoms of pneumonia were valid measures of the antibiotic
treatment of true pneumonia in a study population.
The study had two phases. Phase 1 involved recruiting large
numbers of children with symptoms of acute respiratory infection
and having trained study physicians establish whether pneumonia
(the reference standard for the test) was present or absent. We
purposefully selected hospital outpatient departments as two of the
three study sites to increase the probability that we would find
sufficient numbers of children presenting with symptoms of acute
respiratory infection, and to allow careful training and monitoring
of the study physicians to ensure that the reference standard was
robust. At the third, rural site in Bangladesh, patients were also
identified in the community. Phase 2 involved having trained field
workers interview the caregiver of each child in their home using
DHS and MICS algorithms and alternative tools, either 2 or 4 wk
after their recruitment.
Participants and Selection Criteria
The study participants were children 0–59 mo with physician-
diagnosed clinical pneumonia or ‘‘no pneumonia’’ and their
caregivers. A single WHO technical expert (S. A. Q.) oversaw staff
training and study monitoring to ensure comparability of case
definitions across sites.
Enrollment and Follow-Up
Enrollment procedure. In the two urban settings (Islama-
bad and Dhaka) all children aged 0 to 5 y who were assessed and
managed by hospital outpatient department physicians were
referred to study physicians, who then screened, reassessed, and
diagnosed the children using WHO acute respiratory infection
guidelines and determined their eligibility for inclusion in the
study. Children were enrolled in one of two groups: those with
pneumonia and those with ‘‘no pneumonia’’ [7]. Treatment
provided by outpatient department physicians was recorded.
Children with the following conditions were excluded: recurrent
wheezing (airway disorder/asthma), severe pneumonia requiring
hospitalization (since DHS and MICS surveys typically gather
data on very few of these cases due to their very low period
prevalence in community surveys and since hospitalization, being
Pakistan/Bangladesh-DHS/MICS Pneumonia Validation
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a dramatic event, could induce recall bias), symptoms of chronic
cough of more than 4 wk duration, history of pneumonia within
past 10 d, history of congenital heart disease, and nonresident of
study catchment area. Children with ‘‘cough or cold/no pneu-
monia’’ were frequency matched to pneumonia cases so that in
any one week the age (and sex, in the case of the Bangladesh sites)
distribution of cases of pneumonia and ‘‘cough or cold’’ was
similar.
For each pneumonia case enrolled, a corresponding age-
matched (and sex-matched, in case of Bangladesh sites) ‘‘no
pneumonia’’ case was selected using a computer-generated
randomization list. Details of the recruitment procedures for each
site are given in Box 2.
In the rural setting (Mirzapur), the Village Health Workers
identified all children with pneumonia or ‘‘no pneumonia’’
through their weekly household visits and informed the study
physicians by mobile phone. The study physicians visited at home
all children with ‘‘possible pneumonia’’ and a sample of children
with ‘‘no pneumonia’’ who lived nearest to the case of ‘‘possible
pneumonia.’’ They reassessed using Integrated Management of
Childhood Illness guidelines, and screened and enrolled eligible
children.
DHS and MICS questionnaires and alternative
measurement tools. DHS and MICS surveys both have an
algorithm of questions about the presence or absence of specific
signs and symptoms of suspected pneumonia (denoted as
‘‘symptoms of acute respiratory infection’’ in the DHS survey
and ‘‘suspected pneumonia’’ in the MICS questionnaire; copies of
questionnaires are given in Texts S1, S2, S3). Additional study
tools were developed by ARI Research Cell, Children’s Hospital,
Pakistan Institute of Medical Sciences, Islamabad, and field tested
in both Pakistan and Bangladesh. These tools included a
pneumonia score questionnaire, which consisted of questions on
20 commonly reported signs and symptoms of pneumonia (Box 3),
and a video depicting children in three scenarios: with signs and
symptoms of pneumonia, with severe pneumonia, and with cough
and cold but without pneumonia. The video had nine different
clips of no pneumonia, pneumonia (fast breathing), and severe
pneumonia (lower chest indrawing), one set for each of three age
groups, i.e., up to 2 mo, 2–11 mo, and 12–59 mo. Country-
specific drug charts (flip chart and computer-based) were
developed showing medicines (especially antibiotics) commonly
used in pneumonia and other febrile illnesses in children 0–59 mo
old. All questionnaires, including standard DHS and MICS
questionnaires, were translated into local languages (Urdu and
Bangla—see Texts S1, S2, S3 for copies of questionnaires).
Home follow-up. Using computer-generated randomization
lists, two-thirds of enrolled children were randomly allocated to
follow-up at 2 wk, and one-third to follow-up at 4 wk. The mothers/caretakers were (i) interviewed using DHS/MICS
questions on cough and chest-related short, rapid breathing and
difficult breathing, (ii) asked about specific signs of pneumonia
using a pneumonia score questionnaire, (iii) shown video clips to
find which clip best represented their child’s respiratory illness
episode, and (iv) shown a ‘‘computer-based drug chart’’ and ‘‘a
drug flip chart’’ to identify the drugs the child was treated with.
The order of administering the DHS and MICS questionnaires
was alternated with each child, so that each questionnaire was
administered first on 50% of occasions.
Data Management and Analysis
After double data entry and data cleaning, descriptive statistics
were used to assess the socio-demographic and clinical character-
istics of the study children. Sensitivity and specificity were
calculated to assess the discriminative power of each measurement
Box 1. Key DHS and MICS Acute Respiratory
Infection Questions Used for the Identification
of Children with a Caregiver Report of
Symptoms and Signs of Pneumonia
Q.535 (PDHS)/Q.B3 (BDHS)/Q.CA8 (MICS-P)/Q.C2 (MICS-B):
When (name) had an illness with a cough, did s/he breathe
faster than usual with short, rapid breaths or have difficulty
in breathing?
Q.536 (PDHS)/Q.B4 (BDHS)/Q.CA9 (MICS-P)/Q.C3 (MICS-B):
Was the fast or difficult breathing due to a problem in the
chest or to a blocked or runny nose?
BDHS, Bangladesh DHS; MICS-B, MICS Bangladesh; MICS-P,
MICS Pakistan; PDHS, Pakistan DHS.
Box 2. Details of the Matching Procedures at
the Study Sites
Pakistan For each pneumonia case enrolled a corre-
sponding age-matched ‘‘no pneumonia’’ case was ran-
domly selected. Randomization was done with a comput-
er-generated randomization list with blocks of four (each
having a randomly selected number). For every enrolled
pneumonia case, a ‘‘no pneumonia’’ case was picked as
per the sequence number of the corresponding block.
There were two separate randomization lists: one for
children 0–12 mo and one for those.12–59 mo (to match
for age). Time matching was also ensured, whereby in any
one week a similar number of age-matched ‘‘no pneumo-
nia’’ and pneumonia cases were enrolled.
Bangladesh The enrollment and randomization proce-
dure followed a hierarchical procedure where an attempt
was made to match each pneumonia case in a given week
one-on-one with a non-pneumonia case based on age, sex,
and study physician. The procedure for matching, in order
of preference, was as follows:
1. Matched on case’s sex and age (62 mo), and assessed by
the same study physician
2. Matched on case’s sex and age (62 mo), and assessed by
different study physician
3. Matched on case’s sex and same age category (#12 mo
or .12 mo), and assessed by the same study physician
4. If criteria 1–3 could not be met, we matched on case’s
sex and same age category under different study
physician
If more than one child with no pneumonia was found for a
case (pneumonia), we randomly selected only one control
using computer-generated random numbers. A child was
selected as a control only once. This procedure was
followed at the end of each week throughout the
enrollment period. An additional criterion was added after
2 mo of study enrollment to ensure adequate enrollment
of controls: if matched controls were not found from the
children with ‘‘no pneumonia’’ assessed in the same week
as the cases, controls were selected from children with ‘‘no
pneumonia’’ assessed in the week prior to or following the
week of the case. Eligible and consented pneumonia
patients were excluded from the study if no age- and sex-
matched ‘‘no pneumonia’’ patient could be found.
Pakistan/Bangladesh-DHS/MICS Pneumonia Validation
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tool (DHS, MICS, pneumonia score questionnaire, pneumonia
video) and for various combinations of tools.
For the pneumonia score, a composite score was developed by
adding one point for each symptom or sign present. Sensitivity and
specificity were calculated for each of the composite scores
(ranging from lowest to highest). The intent was to identify a cutoff
that can be used to reach a decision on the presence or absence of
pneumonia. SPSS 11.0 (SPSS Inc.) and STATA 10 (StataCorp)
were used in Pakistan and Bangladesh, respectively.
Sample Size Calculation
Based on baseline estimates of sensitivity of 60%–70% and
specificity of 70%–90% of mother/caregiver recall of symptoms of
acute respiratory infection or suspected pneumonia in predicting
true pneumonia, it was estimated that 300 children under 5 y with
physician-diagnosed pneumonia and 300 with ‘‘no pneumonia’’
should be enrolled at each site in order to estimate sensitivity and
specificity with a precision of 65%.
The study is reported in line with the STARD statement
(checklist in Text S4). The protocol is provided in Text S5.
Results
Enrollment and Follow-Up Status
At the Pakistan site, 752 children were enrolled in the study—
361 with pneumonia and 391 with ‘‘no pneumonia’’—between
October 2010 and February 2011 (Figure 1). Follow-up of 329
pneumonia and 343 ‘‘no pneumonia’’ cases was successfully
carried out; 456 at 2 wk and 216 at 4 wk.
In Bangladesh, between March and August 2011, 1,178
children—589 each in the pneumonia and ‘‘no pneumonia’’
groups—were enrolled, of which 700 were from Dhaka Shishu
Hospital (Figure 2) and 478 from rural Mirzapur (Figure 3). ‘‘No
pneumonia’’ cases were enrolled using recruitment procedures
similar to those used in Pakistan.
Baseline Characteristics of the Study Children
The socio-demographic characteristics and the clinical features
of the study children are presented in Table 1.
Box 3. Pneumonia Score Features
1. Cough
2. Fever
3. Chills/sweats
4. Restlessness
5. Irritability
6. Loss of appetite
7. Abnormally sleepy
8. Wheezing
9. Shortness of breath
10. Fast breathing
11. Flaring of nostrils
12. Refusal to drink
13. Lower chest indrawing
14. Chest pain
15. Difficulty in breathing
16. Vomiting
17. Grunting
18. Blue coloration of skin
19. Coughing up blood
20. Convulsions
Figure 1. Pakistan urban site—flowchart of selection of pneumonia and no-pneumonia cases.
doi:10.1371/journal.pmed.1001422.g001
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Figure 2. Bangladesh urban site—flowchart of selection of pneumonia and no-pneumonia cases in Dhaka Shishu Hospital,
Bangladesh.
doi:10.1371/journal.pmed.1001422.g002
Figure 3. Bangladesh rural site—flowchart of selection of pneumonia and no-pneumonia cases in the rural setting.
doi:10.1371/journal.pmed.1001422.g003
Pakistan/Bangladesh-DHS/MICS Pneumonia Validation
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Discriminative Power of Survey Tools
Sensitivity, specificity, and 95% CIs for the various instruments
that were studied are presented in Tables 2 and 3.
Data are given as percent (95% CI).
DHS/MICS questions. Results at both sites showed poor
discriminative power for DHS and MICS questions. Individual
patterns of sensitivity and specificity varied substantially by study
site and between urban and rural sites (Table 2). Results were
similar for DHS and MICS questions, although not identical,
because of some differences in questionnaire skip patterns. There
was no significant difference in the validity of DHS and MICS
questions at 2- versus 4-wk follow-up intervals (Table 2).
Pneumonia score. As expected, specificity increased and
sensitivity declined with increasing pneumonia score, i.e., the
number of positive symptoms from among the pneumonia score
questions. An area-under-the-curve analysis was performed for the
pneumonia score (see below) and is presented in Figure 4.
Thresholds could be chosen so that the performance was
comparable to DHS/MICS questions (e.g., .9 in Bangladesh)
or to selectively increase test specificity.
Video tool. In Pakistan (where the video was developed and
child images recorded), the video tool had a much higher
discriminative power than in Bangladesh. There was no significant
difference in recall with the video tool at 2 versus 4 wk in any of
the three sites (Table 2).
Recall of Antibiotic Use
In children with pneumonia, antibiotic treatment was recalled
correctly by 66.0% and 66.8% of caregivers using DHS or MICS
questions in Pakistan and Bangladesh, respectively, with no
significant difference between 2- and 4-wk recall. Correct recall
increased to 72.0% using a drug flip chart/photo album and to
71.3% using a computer-based drug chart in Pakistan, and to
78.8% and 81.2%, respectively, in Bangladesh.
Association of Caregiver’s Recall with Socio-Demographic
Characteristics
In both Bangladesh study sites, but not in Pakistan, test
specificities were higher for mothers who had higher levels of
education. At the Bangladesh rural site the test specificity was 59%
for mothers who had secondary or higher education, compared to
a specificity of 37% for mothers whose education level was below
primary. However, at the Bangladesh urban site these figures were
86% and 73%, respectively.
Discussion
Importance of Monitoring Antibiotic Treatment of
Pneumonia
Despite recent falls in pneumonia mortality over the past ten
years, it remains the largest single cause of death in children [8].
It is therefore essential that global and national programs track
the coverage of effective interventions against pneumonia if
Millennium Development Goal 4 is to be achieved. The
antibiotic treatment of pneumonia is highly effective and,
together with immunization, is one of the two main control
strategies [9]. DHS and MICS household surveys are the primary
tools used to measure intervention coverage in low- and middle-
income countries where health information systems are weak, and
are the primary source of information on common childhood
illnesses and treatment coverage. We report here on the first
study evaluating the validity of the estimates of pneumonia
treatment coverage produced by the DHS and MICS survey
instruments and discuss the implications of these findings for
program monitoring.
Validity of DHS/MICS Data for Estimation of Pneumonia
Prevalence
Community-based epidemiological studies have estimated
pneumonia incidence to be about 0.3 episodes per child per year
in children under 5 y in low- and middle-income countries, which
is some 12–18 times lower than the reported incidence of upper
respiratory infections in this age group [10]. This low prevalence
of pneumonia among all children with cough who are surveyed by
DHS and MICS requires that the survey instruments must have
very high specificity to identify pneumonia, otherwise the great
majority of cases identified in the survey will not represent true
cases of pneumonia (as reviewed by Campbell and colleagues in
this PLOS Medicine Collection [11]). An example of this effect can
be seen in a recent Pakistan DHS survey, which reported in 2006–
2007 that 2,508/8,367 (29.9%) children under 5 y had cough and
1,178/8,367 (14.1%) had symptoms consistent with pneumonia
[12]. This ratio of children with reported symptoms and signs of
‘‘cough and cold only’’ versus ‘‘suspected pneumonia’’ of 2:1 is in
marked contrast to that reported in community studies, where this
ratio is typically very much higher, as noted above [13].
DHS and MICS reports clearly caution that these data (denoted
as ‘‘suspected pneumonia’’ in MICS surveys) should not be used as
a proxy measure of the prevalence of pneumonia in the
community. However, many pneumonia control programs in the
developing world, faced with a lack of data on this important
parameter for planning purposes, use the information in this way.
The results of our study show that the specificity of these survey
tools is well below the very high levels required for this proxy to
give an accurate estimation of pneumonia prevalence, and
reinforce that these data should not be used for this purpose as
they will lead to large overestimations of pneumonia prevalence
[11].
Validity of DHS/MICS Data for Estimation of Proportion of
Children with Pneumonia Who Receive Antibiotic
Treatment
DHS and MICS surveys identify children whose caregivers
report that they had symptoms and signs consistent with
pneumonia, and then ask whether these children were treated
with an antibiotic. The validity of this proxy indicator of the
proportion of children with pneumonia who receive antibiotic
treatment is therefore entirely dependent on the validity of DHS/
MICS-reported symptoms and signs of pneumonia as a measure of
true pneumonia. For this to represent a valid denominator for this
important indicator, it is important that a high proportion of
children with ‘‘symptoms of acute respiratory infection’’ (DHS)/
‘‘suspected pneumonia’’ (MICS) actually have ‘‘true’’ pneumonia.
If this proportion is low, then results of monitoring antibiotic
coverage among these children will not only be inaccurate but also
misleading. The results of this study show that DHS and MICS
surveys at both sites have poor discriminative power for the
identification of episodes of pneumonia in young children.
Previous studies have shown that fever is a significant predictor
of pneumonia and that adding fever to WHO criteria increased
the specificity of pneumonia diagnosis [14,15]. Our findings
support this observation, as specificity increased when a question
on the presence of fever was included (Table 3). Since DHS/
MICS surveys currently collect information on the presence of
fever in the last 2 wk, these data could be readily incorporated into
the definition of ‘‘suspected pneumonia.’’ However, the addition of
Pakistan/Bangladesh-DHS/MICS Pneumonia Validation
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Table 1. Baseline characteristics of the study children.
Characteristic Pakistan (Urban) Bangladesh (Urban) Bangladesh (Rural)
Pneumonia
(n=329)
No Pneumonia
(n=343)
Pneumonia
(n=350)
No Pneumonia
(n=350)
Pneumonia
(n=239)
No Pneumonia
(n=239)
Age of child (months) (mean ± SD) 10.6610.1 12.9613.2 12.2612.0 12.8612.8 16.8612.6 18.9614.6
Age category of child (months)
0 to 2 27 (8.2) 34 (9.9) 84 (24.0) 88 (25.1) 1 (0.4) 10 (4.2)
2 to 11 208 (63.2) 210 (61.2) 116 (33.1) 118 (33.7) 84 (35.2) 83 (34.7)
12 to 59 94 (28.6) 99 (28.9) 150 (42.9) 144 (41.1) 154 (64.4) 146 (61.1)
Gender
Male 199 (60.5) 172 (50.1) 204 (58.4) 203 (58.1) 123 (51.5) 124 (51.9)
Female 130 (39.5) 171 (49.9) 146 (41.6) 147 (41.9) 116 (48.5) 115 (48.1)
Siblings
No siblings 73 (22.2) 83 (24.2) 182 (52.0) 166 (47.4) 96 (40.2) 115 (48.1)
One or more 256 (77.8) 260 (75.8) 168 (48.0) 184 (52.6) 143 (59.8) 124 (51.9)
Age category of mothers (years)
#30 266 (80.9) 266 (77.6) 322 (92.0) 314 (89.7) 206 (86.2) 219 (91.6)
.30 63 (19.1) 77 (22.4) 28 (8.0) 36 (10.3) 33 (13.8) 20 (8.4)
Mother’s education
Illiterate 88 (26.7) 55 (16.0) 81 (23.1) 64 (18.3) 32 (13.4) 26 (10.9)
Up to 10th grade 145 (44.1) 157 (45.8) 192 (54.8) 209 (59.7) 175 (73.2) 176 (73.8)
Above 10th grade 96 (29.2) 131 (38.2) 77 (22.0) 77 (22.0) 32 (13.4) 38 (15.9)
Father’s education
Illiterate 42 (12.8) 18 (5.2) 58 (16.6) 52 (15.7) 47 (19.7) 29 (12.1)
Up to 10th grade 148 (45.0) 158 (46.1) 179 (51.1) 153 (43.7) 141 (59.0) 139 (58.1)
Above 10th grade 139 (42.2) 167 (48.7) 113 (32.3) 142 (40.6) 51 (21.4) 71 (29.7)
Father’s occupation status
Employed 322 (97.9) 322 (93.9) 343 (98.0) 345 (98.6) 226 (94.6) 231 (96.7)
Unemployed 7 (2.1) 21 (6.1) 7 (2.0) 5 (1.4) 13 (5.4) 8 (3.3)
Symptoms
Cough and cold 327 (99.4) 343 (100.0) 342 (97.7) 343 (98.0) 228 (95.4) 237 (99.2)
Fever 296 (90.0) 192 (56.0) 153 (43.7) 100 (28.6) 77 (32.2) 42 (17.6)
Breathing problem 51 (15.5) 3 (0.9) 60 (17.1) 34 (9.7) 40 (16.7) 8 (3.4)
Feeding problem 16 (4.9) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Vomiting 10 (3.0) 2 (0.6) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Gastrointestinal problem 5 (1.5) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Irritability 5 (1.5) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Others 2 (0.6) 0 (0.0) 11 (3.1) 21 (6.1) 12 (5.0) 5 (2.0)
Respiratory rate/minute (mean ± SD)
0–2 mo 70.5611.3 46.868.8 63.864.4 43.465.4 61a 46.369.5
2–11 mo 64.5610.1 37.266.0 55.165.1 37.965.9 54.765.5 37.067.2
12–59 mo 57.0610.3 31.264.2 47.466.7 30.665.0 46.866.3 30.764.7
Temperature (6C)
,37.5 236 (71.7) 309 (90.1) 216 (64.1) 293 (85.4) 201 (84.1) 228 (95.6)
$37.5 93 (28.3) 34 (9.9) 121 (35.9) 50 (14.6) 38 (15.9) 11 (4.4)
Findings on auscultation
No significant findings 120 (36.5) 334 (97.4) 194 (55.4) 320 (91.4) 190 (79.5) 233 (97.5)
Crepitations/wheeze 209 (63.5) 9 (2.6) 156 (44.5) 30 (8.5) 49 (20.5) 6 (2.5)
Data are given as number (percent) unless otherwise indicated.
aThere was only one child in the 0–2 age group at the Bangladesh rural site, hence a standard deviation value could not be calculated.
SD, standard deviation.
doi:10.1371/journal.pmed.1001422.t001
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questions on the presence of fever made only modest improve-
ments to the discriminative power. Thus, most children with
‘‘suspected pneumonia’’ (MICS) or ‘‘symptoms of acute respira-
tory infection’’ (DHS) who form the denominator for the
‘‘antibiotic treatment rate’’ do not truly have pneumonia. We
conclude, therefore, that the addition of questions on the presence
of these symptoms and signs would not make sufficiently large
improvements in instrument validity for these to be adopted at
present.
We found no significant difference in caregivers’ recall at 2 and
4 wk, which is contrary to the findings in some previous studies.
The recall sensitivity of caregivers’ reports dropped when the
interview took place after more than 2 wk in a respiratory
questionnaire validation study conducted in Peru [6]. Some
previous studies on maternal recall of breastfeeding duration
showed a drop in mothers’ recall accuracy with time [16,17]. A
more recent study conducted in Kenya also assessed the accuracy
of caregivers’ recall over time and found that it decreased when
Table 2. Discriminative power of DHS/MICS questions about suspected pneumonia and of video for identifying childhood
pneumonia (based on 2-wk and 4-wk recall).
Recall Period/Site Diagnostic Validity DHS Questions MICS Questions Video
2-wk recall period
Pakistan (urban) Sensitivity 64.7 (58.4–70.9) 63.8 (57.5–70.0) 59.8 (53.3–66.2)
Specificity 68.5 (62.5–74.4) 67.2 (61.1–73.2) 78.0 (72.6–83.3)
Bangladesh (urban) Sensitivity 24.6 (17.5–32.9) 25.4 (18.2–33.8) 26.9 (19.5–35.4)
Specificity 81.7 (73.6–88.1) 82.5 (74.5–88.8) 82.5 (74.5–88.8)
Bangladesh (rural) Sensitivity 71.1 (61.0–79.9) 70.1 (60.0–79.0) 26.8 (18.3–36.8)
Specificity 56.5 (45.3–67.2) 56.5 (45.3–67.2) 77.6 (67.3–86.0)
4-wk recall period
Pakistan (urban) Sensitivity 71.4 (62.7–80.0) 69.5 (60.6–78.3) 64.8 (55.6–73.9)
Specificity 69.4 (55.4–77.9) 67.6 (60.7–78.2) 74.8 (66.7–82.8)
Bangladesh (urban) Sensitivity 23.2 (15.8–32.1) 23.2 (15.8–32.1) 28.6 (20.4–37.9)
Specificity 82.7 (74.3–89.3) 83.6 (75.4–90.3) 80.9 (72.3–87.8)
Bangladesh (rural) Sensitivity 72.3 (62.5–80.7) 73.3 (63.5–81.6) 29.7 (21.0–39.6)
Specificity 53.2 (43.4–62.7) 53.2 (43.4–62.7) 83.8 (75.6–90.1)
Overall
Pakistan (urban) Sensitivity 66.9 (61.8–71.9) 65.7 (60.5–70.8) 61.4 (56.1–66.6)
Specificity 68.8 (63.8–73.7) 67.3 (62.3–72.2) 77.0 (72.5–81.4)
Bangladesh (urban) Sensitivity 24.0 (18.7–29.9) 24.4 (19.1–30.3) 27.7 (22.1–33.8)
Specificity 82.2 (76.6–86.9) 83.0 (77.6–87.7) 81.7 (76.1–86.5)
Bangladesh (rural) Sensitivity 71.7 (64.9–77.9) 71.7 (64.9–77.9) 28.3 (22.1–35.1)
Specificity 54.6 (47.3–61.7) 54.6 (47.3–61.7) 81.1 (74.9–86.3)
doi:10.1371/journal.pmed.1001422.t002
Table 3. Sensitivity and specificity of different tools (individually and in combination).
Tools Pakistan (Urban) Bangladesh (Urban) Bangladesh (Rural)
Sensitivity Specificity Sensitivity Specificity Sensitivity Specificity
Fevera 83.0 (72.9–87.3) 31.8 (25.1–34.8) 80.6 (75.0–85.4) 26.5 (20.9–32.7) 86.4 (80.8–90.8) 23.0 (17.3–29.5)
LCIa 42.6 (37.2–47.9) 89.2 (85.9–92.4) 22.7 (17.6–28.5) 83.0 (77.6–87.7) 41.4 (34.5–48.6) 72.4 (65.6–78.6)
Chest paina 46.5 (41.1–51.8) 77.8 (73.4–82.1) 0.4 (0.0–2.3) 97.0 (93.8–98.8) 3.0 (1.12–6.5) 97.4 (94.1–99.2)
DHS+fever 61.2 (56.1–66.6) 72.7 (68.2–77.6) 19.4 (14.6–25.0) 85.7 (80.4–89.9) 62.6 (55.5–69.4) 63.8 (56.6–70.5)
DHS+LCI 33.6 (28.6–38.8) 93.3 (90.6–95.9) 11.6 (7.8–16.3) 90.9 (86.4–94.3) 34.8 (28.2–41.9) 78.6 (72.2–84.1)
DHS+video 44.7 (39.3–50.0) 88.3 (84.9–91.7) 14.5 (10.3–19.5) 92.2 (87.9–95.3) 25.8 (19.8–85.2) 85.2 (79.4–89.9)
DHS+chest pain 39.5 (34.2–44.7) 86.6 (83.0–90.2) 0.4 (0.0–2.8) 99.6 (97.6–100.0) 3.0 (1.1–6.5) 98.5 (95.6–99.7)
DHS+fever+video 42.6 (36.8–48.3) 89.2 (85.9–92.4) 10.7 (7.1–15.3) 93.9 (90.0–96.6) 21.7 (16.2–28.1) 86.7 (81.2–91.1)
DHS+fever+LCI 24.9 (20.2–29.5) 95.6 (93.4–97.7) 9.1 (5.8–13.4) 93.5 (89.5–96.3) 30.8 (24.5–37.7) 84.7 (78.9–89.4)
Data are given as percent (95% CI). Results for both recall periods combined.
aThese variables from the pneumonia score were selected for this analysis because they had the strongest association with pneumonia in screening univariate analyses.
LCI, lower chest indrawing.
doi:10.1371/journal.pmed.1001422.t003
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the recall period was increased to 2 wk from 3–4 d [18]. In our
study, the lack of fall in performance with the longer recall period
suggests that DHS/MICS surveys may be able to adopt a longer
recall period for this question, thus increasing the period
prevalence of true pneumonia cases detected in the survey. This
possibility should be studied further, because since increasing the
recall period, and thus the true period prevalence, can be expected
to improve the validity of the indicator [11].
The sensitivities and specificities of the DHS/MICS survey
instruments varied substantially by study site and by urban and
rural setting (Table 2), reflecting different cultural factors, such as
caregiver education, and making comparisons across countries or
time periods difficult to interpret. These results have important
implications for monitoring programs because these instruments
are used to track progress over time (typically with serial surveys in
different populations within a country) and to identify countries
that have low intervention coverage in comparison to others.
These findings urge caution in using DHS/MICS data for these
purposes.
We show that the use of video material shows some potential to
complement current DHS/MICS surveys and result in increased
specificity for identification of episodes of pneumonia. However,
substantial improvements in test specificity were found only in
Pakistan, where the video was made, and were not found in
Bangladesh. This finding is not unexpected and may relate to the
fact that Pakistani children look somewhat different from
Bangladeshi children, which is likely to have influenced caregiver
responses. Moreover, we elected a priori to focus the video on
showing fast breathing and lower chest indrawing. Ethnographic
studies from this region have shown that mothers have varying
perceptions and concepts regarding childhood pneumonia, and
many caregivers do not associate fast breathing with pneumonia
[19–21]. The fixed sequence of clips might also have influenced
caregiver responses. The potential use of this video tool presents
practical and logistical challenges, not least of which is that each
individual country may be required to develop their own video.
The improved discriminative power with the use of the video in
Pakistan is promising, and we recommend that video presentation
be explored further in an attempt to further improve its
performance.
In children with pneumonia, antibiotic treatment was recalled
correctly by two-thirds of caregivers using DHS or MICS
questions in Pakistan and Bangladesh, with no significant
difference between 2- and 4-wk recall. Correct recall increased
with a drug flip chart/photo album or a computer-based drug
chart. Thus, the validity of the DHS and MICS questions in
correctly identifying antibiotic treatment for pneumonia improved
with specific and more structured questions about the medicines or
with the use of illustrations of common treatments. Although drug
charts performed better than DHS/MICS questions at all three
sites, using them in periodic household surveys may be challeng-
ing. There may be a very large number of available medicines in
any given area, and new medicine brands are introduced often, so
frequent revisions would be required.
Study Limitations
The findings of the survey may have been biased by some aspects
of the study design. DHS and MICS surveys are conducted in very
diverse urban and rural settings. We attempted to reflect this
through the urban and rural study sites selected for study. However,
it is possible that the rural site in Bangladesh is not typical because of
the ongoing research studies in that population. Furthermore, the
urban site in Bangladesh included patients from an expanded urban
and peri-urban catchment area, resulting in a relatively high rate of
loss to follow-up and delayed follow-up. Thus, our findings may not
be generalizable to some settings in low- and middle-income
countries. Further studies, in particular in settings with high
Plasmodium falciparum malaria transmission to explore the general-
izability and to check the consistency of these findings, are
recommended on this important issue. Nevertheless, the fact that
our main study conclusions were confirmed in all three study
settings suggests that the main findings may be widely relevant.
We selected study sites with investigators highly experienced in
similar studies and employed a single technical expert to conduct
the clinical training and oversee the monitoring of research staff in
Figure 4. Validity of composite pneumonia score.
doi:10.1371/journal.pmed.1001422.g004
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an attempt to reduce the potential for artifactual differences in
study implementation across sites. Nevertheless, some of the
differences shown between study sites may reflect some variation
in application of methods across sites.
Mothers who take their children to a secondary or tertiary care
center do not represent a random sample of all mothers who take
part in DHS and MICS surveys. This is likely to influence results.
We expect that these mothers will be more educated and show
better recognition of signs of pneumonia in their children. To the
extent that this is true, we may have overestimated the sensitivity
and specificity of DHS/MICS questions. Furthermore, it is also
likely that attendance at a hospital makes the episodes more
memorable (and thus subject to better recall by the caregiver) and
thus may once again lead to overestimation of specificity.
It is possible that the ‘‘case mix’’ in the hospital setting is
different from that found in community surveys. We attempted to
minimize this by excluding cases of severe pneumonia (rarely
found in community surveys due to very low 2-wk period
prevalence) and by adopting a matched group who had a
respiratory illness (cough and cold) rather than studying healthy
children. Nevertheless, this may have influenced our estimates of
sensitivity and specificity. Thus, study procedures may have
influenced caregiver recall. However, our main finding is that
specificity levels associated with DHS and MICS questions are
much too low to provide a robust basis for a pneumonia treatment
rate indicator. We believe that the biases noted above tend to lead
to an overestimation of specificity, and so we consider that our
main conclusions about poor discriminative ability should remain
valid. In addition, the level of specificity that we found is much
lower than would be required, suggesting moderate effects of bias.
Conclusions
Monitoring antibiotic treatment of pneumonia is essential for
national and global programs. Despite this, we believe this is the
first study to assess the validity of current surveys to measure this
program indicator. Given the very large investment of human and
financial resources in these surveys and their importance to child
health programs, it is remarkable that there has been so little
published data from research on this key issue. In the context of a
low true prevalence of pneumonia, the DHS/MICS questions to
define children with ‘‘suspected pneumonia’’ (MICS term) has a
low yield for pneumonia, and thus most of these children do not
have true pneumonia. This finding reinforces DHS and MICS
recommendations that these measures not be used as a proxy for
pneumonia prevalence, as using these measures will result in
substantial overestimates.
We found the discriminative power (in particular the specificity)
of a construct of caregiver-reported symptoms and signs of acute
respiratory infection to be low for true pneumonia, as measured by
DHS and MICS questionnaires; therefore, the use of such data
from these surveys can be misleading for measuring antibiotic
treatment rates. Using such data could lead to incorrect policy
decisions having programmatic implications. Although the alter-
native tools evaluated in this study did not perform markedly
better than DHS and MICS questions, we have presented some
options for improving their specificity. Furthermore, the sensitiv-
ities and specificities of DHS and MICS survey instruments varied
substantially by site, reflecting different cultural factors, such as
caregiver education, and making comparisons across countries or
time periods difficult to interpret. These results suggest that data
from these surveys should not be used for the purpose of
monitoring antibiotic treatment rates in children with pneumonia
at the present time.
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Editors’ Summary
Background. Pneumonia is a major cause of death in
children younger than five years across the globe, with
approximately 1.2 million children younger than five years
dying from pneumonia every year. Pneumonia can be
caused by bacteria, fungi, or viruses. It is possible to
effectively treat bacterial pneumonia with appropriate
antibiotics; however, only about 30% of children receive
the antibiotic treatment they need. The Millennium Devel-
opment Goals (MDGs) are eight international development
goals that were established in 2000. The fourth goal (MDG 4)
aims to reduce child mortality, specifically, to reduce the
under-five mortality rate by two-thirds, between 1990 and
2015. Given that approximately 18% of all deaths in children
under five are caused by pneumonia, providing universal
coverage with effective treatments for pneumonia is an
important part of MDG 4.
To ensure that MDG 4 targets are met, it is important to
measure progress in providing effective treatments. For
pneumonia, one of the key indicators for measuring progress
is the proportion of children with pneumonia in a population
who receive antibiotic treatment, also known as the
antibiotic treatment rate. The antibiotic treatment rate is
often measured using surveys, such as the Demographic and
Health Surveys (DHS) and Multiple Indicator Cluster Surveys
(MICS), which collect nationally representative data about
populations and health in developing countries.
Why Was This Study Done? Concerns have been raised
about whether information collected from DHS and MICS is
able to accurately identify cases of pneumonia. In a clinical
setting, pneumonia is typically diagnosed based on a
combination of physical symptoms, including coughing,
rapid breathing, or difficulty breathing, and a chest X-ray.
The surveys rely on information collected from interviews of
mothers and primary caregivers using structured questions
about whether the child has experienced physical symptoms
in the past two weeks and whether these were chest-related.
The DHS survey labels this condition as ‘‘symptoms of acute
respiratory infection,’’ while the MICS survey uses the term
‘‘suspected pneumonia.’’ Thus, these surveys provide a proxy
measure for pneumonia that is limited by the reliance on the
recall of symptoms by the mother or caregiver. Here the
researchers have evaluated the use of these surveys to
discriminate physician-diagnosed pneumonia and to provide
accurate recall of antibiotic treatment in urban and rural
settings in Pakistan and Bangladesh.
What Did the Researchers Do and Find? The researchers
identified caregivers of 950 children under five years with
pneumonia and 980 who had a cough or cold but did not
have pneumonia from urban and rural settings in Pakistan
and Bangladesh. Cases of pneumonia were identified based
on a physician diagnosis using World Health Organization
guidelines. They randomly assigned caregivers to be inter-
viewed using DHS and MICS questions with either a two- or
four-week recall period. They then assessed how well the
DHS and MICS questions were able to accurately diagnose
pneumonia and accurately recall antibiotic use. In addition,
they asked caregivers to complete a pneumonia score
questionnaire and showed them a video tool showing
children with and without pneumonia, as well as a
medication drug chart, to determine if these alternative
measures improved the accuracy of pneumonia diagnosis or
recall of antibiotic use. They found that both surveys, the
pneumonia score, and the video tool had poor ability to
discriminate between children with and without physician-
diagnosed pneumonia, and there were no differences
between using two- or four-week recall. The sensitivity
(proportion of pneumonia cases that were correctly identi-
fied) ranged from 23% to 72%, and the specificity (the
proportion of ‘‘no pneumonia’’ cases that were correctly
identified) ranged from 53% to 83%, depending on the
setting. They also observed that prescribed antibiotics for
pneumonia were correctly recalled by about two-thirds of
caregivers using DHS questions, and this increased to about
three-quarters of caregivers when using a drug chart and
detailed enquiry.
What Do These Findings Mean? The findings of this
study suggest that the current use of questions from DHS
and MICS based on mother or caregiver recall are not
sufficient for accurately identifying pneumonia and antibiotic
use in children. Because these surveys have poor ability to
identify children who have true pneumonia, reported
antibiotic treatment rates for children with pneumonia
based on data from these surveys may not be accurate,
and these surveys should not be used to monitor treatment
rates. These findings should be interpreted cautiously, given
the relatively high rate of loss to follow-up and delayed
follow-up in some of the children and because some of the
settings in this study may not be similar to other low-income
settings.
Additional Information. Please access these websites via
the online version of this summary at http://dx.doi.org/10.
1371/journal.pmed.1001422.
N More information is available on the United Nations goal to
reduce child mortality (MDG 4)
N The World Health Organization provides information on
pneumonia, its impact on children, and the global action
plan for prevention and control of pneumonia
N More information is available on Demographic and Health
Surveys and Multiple Indicator Cluster Surveys
N KidsHealth, a resource maintained by the Nemours
Foundation (a not-for-profit organization for children’s
health) provides information for parents on pneumonia (in
English and Spanish)
N MedlinePlus provides links to additional information on
pneumonia (in English and Spanish)
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